| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 12.7k | $38.54 | $489.5k | | 10/22/2019 |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 17.3k | $32.76 | $566.7k | | 10/22/2019 |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 15k | $29.26 | $438.9k | | 10/22/2019 |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 15k | $16.90 | $253.5k | | 10/22/2019 |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 100k | $11.95 | $1.2M | | 10/22/2019 |
| 10/22/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Disposition | Stock Option (Right to Buy) | 22.5k | $11.01 | $247.7k | | 10/22/2019 |
| 05/23/2019 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 22.5k | $11.01 | $247.7k | | 05/23/2019 |
| 05/31/2018 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 35k | $6.25 | $218.8k | | 05/31/2018 |
| 03/26/2018 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 100k | $11.95 | $1.2M | | 03/26/2018 |
| 06/12/2017 | Adverum Biotechnologies, Inc. | ADVM | Grant | Common Stock | 22.7k | $0.00 | $0 | | 06/12/2017 |
| 06/12/2017 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 33.6k | $2.75 | $92.4k | | 06/12/2017 |
| 05/24/2017 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 15k | $16.90 | $253.5k | | 05/24/2017 |
| 06/14/2016 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 10k | $5.99 | $59.9k | | 06/14/2016 |
| 05/26/2016 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 15k | $29.26 | $438.9k | | 05/26/2016 |
| 05/11/2016 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 381k | $4.14 | $1.6M | | 05/11/2016 |
| 12/09/2015 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 910k | $9.04 | $8.2M | | 12/09/2015 |
| 09/30/2015 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 17.3k | $32.76 | $566.7k | | 09/30/2015 |
| 08/26/2015 | ALDER BIOPHARMACEUTICALS INC | ALDR | Grant | Stock Option (Right to Buy) | 12.7k | $38.54 | $489.5k | | 08/26/2015 |
| 01/01/2015 | Eiger BioPharmaceuticals, Inc. | EIGR | Grant | | 140k | $19.53 | $2.7M | | 01/01/2015 |
| 06/19/2014 | Eiger BioPharmaceuticals, Inc. | EIGR | Grant | | 277.5k | $14.40 | $4M | | 06/19/2014 |
| 04/21/2014 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 10k | $14.20 | $142k | | 04/21/2014 |
| 01/15/2014 | SANGAMO THERAPEUTICS, INC | SGMO | Exercise | Stock Option (Right to Buy) | 8.3k | $5.03 | $41.9k | | 01/15/2014 |
| 01/15/2014 | SANGAMO THERAPEUTICS, INC | SGMO | Sale | Common Stock | 8.3k | $18.68 | $155.7k | | 01/15/2014 |
| 06/01/2011 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 10k | $6.41 | $64.1k | | 06/01/2011 |